HomeAI · summaries
Storia in 15 fonti
What's the deal with peptides? The hyped market under U.S. review
Explore the controversial rise of peptides, their FDA review, and concerns over safety and clinical evidence in wellness trends.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
nbcnews.com
What to know about the seven peptides an FDA advisory panel is set to review this week
The committee will discuss whether compounding pharmacies can make the peptides in question. But FDA scientists say there’s little — if any — evidence they work in humans.
- ·
fortune.com
The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune
As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1 boom—only this time with even murkier science.
